Neurology:多发性硬化症患者多重死亡原因分析

2020-01-14 xing.T MedSci原创

由此可见,归因于MS的死亡通常是由感染(尤其是与呼吸道和泌尿道有关的感染)、与晚期残疾和行动不便相关疾病,例如吸入性肺炎以及男性慢性呼吸道疾病所引起的。所有这些都可能被改善;减少这些并发症发生频率或严重程度的干预措施可以提高MS患者的生存率。

近日,神经病学领域权威取杂志Neurology上发表了一篇研究文章,该研究旨在通过评估MS与死亡证明上列出的其他死亡原因之间的关系,更好地了解导致多发性硬化症(MS)患者死亡的原因。

研究人员评估了1986年至2013年期间加拿大不列颠哥伦比亚省所有死亡成人(≥18岁)的多重死亡原因数据。死亡证明上列出的所有原因,无论是主要原因还是诱因,均被视为“任何提及”的原因。研究人员通过对数回归分析,对年龄、性别和年份进行校正(Bonferroni校正的α=0.002),通过Logistic回归评估了死亡证明中MS与其他死亡原因之间的关联。研究结果也按性别进行分类。

在771288例死亡个体中,有2153例患者被提到MS。如果提到了MS(相比于未提及),则发生特定疾病导致死亡的可能性更大:呼吸道感染(校正比值比[aOR]为3.03 [95%置信区间(CI),2.73-3.36])、误吸肺炎(aOR为7.15 [95%CI,6.23-8.22])、尿路感染(UTI)(aOR为10.2 [95%CI,8.7-12.0])、其他感染,包括败血症(aOR为1.34 [95%CI, [1.15–1.56])和皮肤病(aOR为5.06 [95%CI,3.96-6.46])。尿路感染(男性:aOR为14.9 [95%CI,11.5-19.3];女性:aOR为8.00 [95%CI,6.53-9.81])和慢性呼吸系统疾病(男性:aOR为1.36 [95%CI,1.14-1.63];女性: aOR为0.97 [95%CI,0.84-1.13]存在性别差异。

由此可见,归因于MS的死亡通常是由感染(尤其是与呼吸道和泌尿道有关的感染)、与晚期残疾和行动不便相关疾病,例如吸入性肺炎以及男性慢性呼吸道疾病所引起的。所有这些都可能被改善;减少这些并发症发生频率或严重程度的干预措施可以提高MS患者的生存率。
 
原始出处:

Katharine Harding,et al.Multiple cause of death analysis in multiple sclerosis A population-based study.Neurology.2020.https://n.neurology.org/content/early/2020/01/13/WNL.0000000000008907

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2000957, encodeId=454a200095e56, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu May 21 02:35:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903529, encodeId=106d1903529b9, content=<a href='/topic/show?id=c8aa6335ed5' target=_blank style='color:#2F92EE;'>#死亡原因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63357, encryptionId=c8aa6335ed5, topicName=死亡原因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Sun Sep 06 21:35:00 CST 2020, time=2020-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983097, encodeId=6268198309e99, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73594, encryptionId=a7a7e359478, topicName=硬化症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Thu Jul 23 01:35:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890088, encodeId=3c791890088fa, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Sat Jun 13 11:35:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2020-05-21 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2000957, encodeId=454a200095e56, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu May 21 02:35:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903529, encodeId=106d1903529b9, content=<a href='/topic/show?id=c8aa6335ed5' target=_blank style='color:#2F92EE;'>#死亡原因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63357, encryptionId=c8aa6335ed5, topicName=死亡原因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Sun Sep 06 21:35:00 CST 2020, time=2020-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983097, encodeId=6268198309e99, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73594, encryptionId=a7a7e359478, topicName=硬化症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Thu Jul 23 01:35:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890088, encodeId=3c791890088fa, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Sat Jun 13 11:35:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2000957, encodeId=454a200095e56, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu May 21 02:35:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903529, encodeId=106d1903529b9, content=<a href='/topic/show?id=c8aa6335ed5' target=_blank style='color:#2F92EE;'>#死亡原因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63357, encryptionId=c8aa6335ed5, topicName=死亡原因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Sun Sep 06 21:35:00 CST 2020, time=2020-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983097, encodeId=6268198309e99, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73594, encryptionId=a7a7e359478, topicName=硬化症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Thu Jul 23 01:35:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890088, encodeId=3c791890088fa, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Sat Jun 13 11:35:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2000957, encodeId=454a200095e56, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu May 21 02:35:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903529, encodeId=106d1903529b9, content=<a href='/topic/show?id=c8aa6335ed5' target=_blank style='color:#2F92EE;'>#死亡原因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63357, encryptionId=c8aa6335ed5, topicName=死亡原因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Sun Sep 06 21:35:00 CST 2020, time=2020-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983097, encodeId=6268198309e99, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73594, encryptionId=a7a7e359478, topicName=硬化症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Thu Jul 23 01:35:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890088, encodeId=3c791890088fa, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Sat Jun 13 11:35:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2020-06-13 jml2009

相关资讯

Neurology:儿童和成人发病的多发性硬化症患者生活质量的决定因素

由此可见,POMS患者和AOMS患者的QoL无差异。该研究结果支持通过减少神经系统残疾和改善心理状况来改善MS患者QoL的方法。

多发性硬化症极易误诊,身体出现这些症状需要注意啦!

多发性硬化症患者常见的症状有视力下降、头晕、单侧肢体麻木无力、走路不稳、三叉神经痛等症状。由于疾病累及部位广泛,反复发作后可能导致瘫痪甚至危及生命。但不同患者症状差别很大,加上有些症状并不典型,所以经常被误诊。

FDA批准了诺华多发性硬化症药物Gilenya的仿制药

FDA批准Sun制药、Biocon和HEC Pharm公司针对诺华的Gilenya(芬戈莫德)的首个仿制药营销申请,用于治疗成人复发型多发性硬化症(MS)。

美国临床医生最喜欢哪款多发性硬化症药物?诺华、默克还是Biogen的?

尽管来自诺华、默克和Biogen的新型多发性硬化症药物今年已进入市场并被寄予厚望,但临床医生们对这些药物并不那么感兴趣。一位分析师说,反而是尚未批准的一种扩展用途的多发性硬化症(MS)疗法引起了"一致的兴趣"。

JEM:南医大新发现罕见病多发性硬化症的一个致病蛋白

多发性硬化症是一种罕见病,患者身体逐渐硬化,被称为“木偶人”。记者29日从南京医科大学了解到,该校科研人员新近发现一种与多发性硬化症相关的蛋白,有望为患者提供新的治疗思路。

欧洲药品管理局CHMP建议批准7种药物上市和2种药物扩展适应症

欧洲药品管理局的人类用药产品委员会(CHMP)在11月的会议上,建议批准7种药物以及2种药物的扩展。